Category: Fundamentals Angiotensin II type 1 receptor blockers (ARBs) do not block degradation of vasoactive substances (bradykinin, enkephalins) and may not cause adverse effects, such as cough, due to ACE inhibitor–induced bradykinin accumulation.
No comments :
Post a Comment